BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Jade Biosciences Inc.

Headquarters: Waltham, MA, United States of America
Year Founded: 2024
Status: Private

BioCentury | Nov 5, 2024
Deals

Novo to use Ascendis’ TransCon for once-monthly GLP-1R agonist

Deals report: AbbVie-EvolveImmune, Genmab-Revitope and GSK-Chimagen partner for T cell engagers 
BioCentury | Nov 1, 2024
Finance

How Fairmount’s Paragon incubator steered two more companies to NASDAQ

In BioCentury’s Public Equity Report: Paragon-backed Jade and Crescent each reverse-merging with public companies, raising combined $500M
BioCentury | Oct 25, 2024
Management Tracks

Chinook veterans join Jade

Plus: Apnimed hires Ramzi Benamar as CFO and an update from PhotonPharma
BioCentury | Aug 9, 2024
Finance

Venture Report: Pair of crossover rounds for precision oncology, peptide biotechs

Plus: Financings for newcos Nilo, Jade, Red Queen
Items per page:
1 - 4 of 4